We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Inspicio | INP | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 226.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 226.00 | 226.00 |
| Top Posts |
|---|
Posted at 28/7/2011 15:10 by praipus Barclays Bank PLC iPATH Sec 2006 Lkd to MSCI India Total Return FundIndia From the iPath website: The iPath® MSCI India Index ETNs are linked to the MSCI India Total Return Index (the "Index"). The Index is a free-float-adjusted market capitalization index designed to measure the market performance, including price performance and income from dividend payments, of Indian equity securities. The Index seeks to represent approximately 85% of the free-float-adjusted market capitalization of equity securities by industry group within India. As of September 30, 2009, the Index was comprised of 60 companies listed on the National Stock Exchange of India (the "NSE"). |
Posted at 16/9/2007 16:59 by jonwig Hi, Honiton.I must own up that I sold earlier this month - but other stuff, too. I suppose I'm very dubious about the state of the market for a while, but INP is one I will buy back into in due course. I may be wrong - it won't be the first time! |
Posted at 26/6/2007 09:18 by jonwig Hi, Honiton.Well, INP are forecast to earn 7.5p (P/E 23.1) to end-2007 and 10.8p (P/E 16.1) to end-2008. For ITRK, currently on a historic P/E of 19, the corresponding forecasts are 48.2p (P/E 20.0) and 55.2p (P/E 17.4). So, allowing for 2007 as a bedding-down year for INP, there should be some upside to 210p. Of course, that leaves out growth through further acquisition and the synergies which go with that and, of course, the chance that we might get bought out ourselves. If there were to be a bid for ITRK (a more established company), it might be in that one's interest to make a defensive bid for us, perhaps. |
Posted at 16/6/2007 12:23 by petersmith6 INP taken over by SGS?now that would be funny.i work for scientifics who used to be owned by SGS..i could go full circle...joy .better practis saying Société Générale de Surveillance ...we got told of if we didnt say it properly. |
Posted at 13/6/2007 16:38 by honiton I don't know what to make of institutional share holder changes. Some ofit is driven by changes in manager or style or just their overall stanceand exposure to that sector. I have a holding in Rothschild who have a holding in Cycladic Capital who have a holding in INP. They are pretty switched on bunnies so happy to keep with for the moment.Gradually buying into INP at prices ranging from 119,123 and 176. Expect AGM trading statement to be positive and for INP to either grow or be taken over by the likes of SGS. Hopeful for maiden dividend but might be a year or so off. |
Posted at 13/6/2007 15:55 by jonwig Sorry for being obtuse, Honiton.We can see now why INP are keen to beef up their size, in the face of consolidation activity in the sector. Only an addition of 100,000 shares, but "every little helps" as your friend Tesco says: The Company received notification on 12 June 2007 that Polar Capital Partners has an interest in 2,718,600 Ordinary Shares, representing approximately 3.08 per cent. of the Company's issued share capital. The Ordinary Shares are registered under Goldman Sachs Intl Nominees. |
Posted at 08/5/2007 17:06 by honiton Oh well. No need to sell INP. Just like TESCO really. Over 3years 6 months I have more than doubled my money in Tescos. So boring as well? but then you can't complain at that kind of return.where did I get this tip from. The difficulty finding a spot in their carpark vis. Asda or Sainsbury's. |
Posted at 07/5/2007 16:10 by honiton Jonwiggood spotting. At the moment the market is hot for any service companies e.g. RTR, INP, SWG, WSP, WHY. Don't see any reason to sell INP yet. |
Posted at 23/3/2007 15:21 by jonwig And Citywire;Small may have been beautiful towards the end of the 20th century, but in these days of globalisation, increased regulation, high barriers to entry and growing world trade, size has become increasingly important. In some areas you need to be big to compete, and one of these is in the testing of oil and petroleum in terms of quantity and quality. If results are to mean anything, tests need doing in the same way by the same company when oil is piped into a tanker and when it's pumped out at the other end of its voyage. The highly fragmented nature of the international testing market is why AIM-listed international inspection and testing group Inspicio (INP) was formed nearly two years ago, explains chief executive Mark Silver. Group turnover for the 12 months to 31 December was £161.9 million against £26.2 million in 2005. The comparative figures for 2005 include head office costs from the date of incorporation in April and the trading results of the petroleum specialists Inspectorate from its acquisition in October 2005. Close to half the turnover came from America. Although Inspicio is involved with metal and mineral testing, where high gold and other precious metal prices increased analysis requirements, the business was driven by oil and petroleum testing. South America was more diversified with new laboratories in Venezuela and water testing in Argentina. Europe, the Middle East and Africa accounted for £52.4 million or 41.5% of sales while Asia chipped in with £11.3 million, or 9.1%. Earnings before exceptional items, amortisation, interest and tax were £7.6 million compared to a loss of £500,000 in the 38 weeks to 31 December 2005. Group profit before interest and tax was £3.2 million against of loss last time of £4.3 million, in-line with expectations. There is no dividend. Market consensus was for pre-tax profit of £5.42 million and earnings per share of 3.92p. The shares fell 5.25p to 165p giving the group a stock market value of £146.5 million. The company has seen 70% growth and its shares have outperformed the market by 27% over the last year. Investors in Inspicio include Framlington's UK Smaller Co's fund and F&C's open ended UK Smaller Co's Fund. Cycladic, JO Hambro and SG Asset Management also have stakes. Broker Bridgewell kept its buy recommendation and said it would review its 210p target price. It noted the results were in line with its forecasts and reflect excellent performance across its divisions, but that forecast higher interest charges would lower forecasts by about 5%. Altium also maintained its buy recommendation with a 200p price target. 'Encouragingly, the Inspectorate turnaround is proceeding to plan and the wider market outlook remains positive,' the broker wrote in a note to investors. With turnover of £126.1 million, the Inspectorate side of the Inspicio group is by far the biggest. Operating profit before exceptional items was £5.2 million compared to a loss of £600,000 in the 12 months to 31 December 2005 on a pro forma basis. The balance of turnover came from the Environmental Services Group with £28.1 million in the eight months since acquisition and the Eclipse Scientific Group with £7.7 million with 20 weeks. The Environmental Services Group, bought from Carillion for £16 million, specialises in the testing of ground used for development, anything from a house to a football stadium. It includes businesses in the soil, environmental and building testing sector and provides laboratory-based tests and consultancy services. On 11 August 2006, Inspicio acquired the Eclipse Scientific Group for £47 million. It concentrates on food testing and is a market leader in both the UK and Ireland. There were a number of smaller acquisitions costing around £4.9 million which added £1.1 million to turnover. These included a majority stake in Inspectorate's Libyan agent, while the minority interest in Hungary was acquired outright. Inspectorate also bought an agent in Portugal and expanded its metals and minerals services in Australia by taking over the Renton Laboratory. Group margins were 4.2% against a pro forma loss last time of 0.6%. The turnaround was achieved by reducing costs, taking on a larger proportion of higher margin testing work and higher prices, explains Silver. Margins are expected to reach 8% in the second half of this year. Analysts were forecasting profit before tax of £13.2 million for 2007, but this is expected to increase after the analysts' meeting later today. |
Posted at 23/3/2007 13:02 by cambium Inspicio INP Altium Capital Buy 166.00p 200.00p - Reiteration 23-Mar-07 Inspicio INP Daniel Stewart Hold 166.00p 190.00p - Reiteration |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
